Navigation Links
Life Sciences Discovery Fund makes company grants in health-related technologies
Date:7/24/2012

SEATTLE, Washington, July 23, 2012 The Life Sciences Discovery Fund (LSDF) today announced nearly $570,000 in awards in its inaugural corporate grant program to support commercialization of new health and health-care products by four early-stage Washington-based companies.

Three of the new "PreCede" grants focus on improving the management of serious medical conditions. Glenn Kawasaki of Carepeutics, Inc., will test a technology for predicting patient responses to anticancer drugs to inform treatment decisions. Tom Sanko of EchoGuide Medical, Inc. (formerly Harpoon Navigation, Inc.), will develop and test an ultrasound-guided system for placing catheters in the brain to drain excess cerebrospinal fluid. Robert Wilcox of Viket Medical Corporation will test a new approach for removing blood clots from the brains of individuals who have suffered a type of stroke called intracranial hemorrhage.

The fourth grant, to Thomas Schulte of Nexgenia, Inc., will optimize and scale up novel reagents to improve the speed and sensitivity of clinical assays for diagnosing various diseases.

The PreCede grant competition is designed to help position early-stage Washington life sciences companies for near-term equity investment. PreCede grants support research and development activities focused on validating the commercial merit of promising health-related technologies.

"LSDF has provided grant funding since 2007 to accelerate the movement of promising technologies into the commercial marketplace," stated LSDF Executive Director John DesRosier. "Today's grants represent LSDF's first dedicated mechanism to provide funding directly to companies. We have been encouraged and heartened by the strong support of and interest in this grant program from Washington's life sciences sector."

Washington Biotechnology & Biomedical Association President Chris Rivera noted that PreCede grants meet a vital need within the state's life sciences communi
'/>"/>

Contact: Cathyryne Manner
manner@lsdfa.org
206-456-9583
Life Sciences Discovery Fund
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Lauren Sciences LLCs research team at Ben-Gurion University awarded Campbell Foundation grant to develop a V-Smart therapeutic for neuro-HIV
2. Natural Sciences Repository Publishes Chromatography and Acidic Compounds Resources
3. New Anthropology and Archaeology Resources Published at Sciences Social Network
4. Novel Natural Sciences Repository Opens Web Portal
5. UCSC physicist Alexander Sher named Pew Scholar in the Biomedical Sciences
6. UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
7. Ivy Neurological Sciences Internship program funded at TGen
8. Hutchinson Center president elected to American Academy of Art and Sciences
9. Washingtons Life Sciences Discovery Fund awards commercialization grants
10. Evolutionary information improves discovery of mutations associated with diseases
11. Discovery improves understanding of early onset inflammatory disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... R.I. (PRWEB) , ... July 07, 2015 , ... Summer ... the proper precautions, however, so Amica Insurance is sharing some safety tips. , Jean ... sports and gardening: , Leisure activities/sports, , Start slowly. Going ...
(Date:7/7/2015)... ... July 07, 2015 , ... Healthpointe is proud to announce ... an anesthesiologist and pain management specialist, will be evaluating and treating patients with orthopedic ... , After receiving his Bachelor of Science in Biology from the University of the ...
(Date:7/7/2015)... ... July 07, 2015 , ... Parents and guardians of ... A Forever Recovery, an open-ended holistic treatment center for drug and alcohol abuse located ... Use and HIV Research has shown a significant increase in the “club drug” use ...
(Date:7/7/2015)... ... , ... FSAstore.com today announced the launch of its sister site ... simple to use, spend and manage HSA funds with innovative tools including an ... to a report by Devenir , approximately 13.8 million Americans have an HSA, ...
(Date:7/7/2015)... ... July 07, 2015 , ... With a new community program in the San ... and announced a new charity campaign to raise funds in support of programs for ... which was created especially to care for the special needs of our soldiers. ...
Breaking Medicine News(10 mins):Health News:Amica Insurance Has 7 Summer Safety Tips 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 2Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 3
... Friday, July 11, at ... 10:00 P.M. (ET/PT), Produced by Reveille and Hosted ... Students Take On the Physical Challenge to Get Into Better Shape, ... The N, the network totally for and,about teens, and the award-winning production company ...
... Initiative, The University of Melbourne in Melbourne Australia will ... to life sciences. , The initiative will develop the ... to life sciences research in the world. , Funding ... State Government, as announced by the Victorian Premier John ...
... set go to lane 1? , Researchers at ... loud sounds and reaction time are reporting findings that may ... Olympics. , Led by Dave Collins, professor of physical ... the loud starter,s pistol at the Olympic Games would allow ...
... June 18 Transcept,Pharmaceuticals, Inc. today announced that ... present at the Jefferies 2nd Annual,Healthcare Conference in ... at 9:30,AM Eastern Time., The presentation will ... About Transcept Pharmaceuticals, Transcept Pharmaceuticals, Inc. ...
... services into consumers, homes, BOSTON and SAN ... Well(TM) today announced the availability of the Online,Healthcare ... to offer online care services to consumers and ... healthcare,providers to make themselves available to consumers for ...
... ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer and ... it will participate at the Piper,Jaffray Europe Conference ... Dale, President and CEO of ATS Medical will ... http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ), Attendance at the conference is ...
Cached Medicine News:Health News:The N Shapes Up This Summer With the New One-Hour Teen Reality Series, The N's Student Body 2Health News:The N Shapes Up This Summer With the New One-Hour Teen Reality Series, The N's Student Body 3Health News:The N Shapes Up This Summer With the New One-Hour Teen Reality Series, The N's Student Body 4Health News:$100 million supercomputing program boosts Australian medical research capacity 2Health News:Sprinters closest to starter pistol have advantage over those farther away, says study 2Health News:Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference 2Health News:American Well Launches the Online Healthcare Marketplace 2Health News:American Well Launches the Online Healthcare Marketplace 3Health News:ATS Medical to Participate at the Piper Jaffray Europe Conference 2
(Date:7/7/2015)... , July 7, 2015 A power morcellator ... has been settled for an undisclosed amount, Bernstein Liebhard ... filed in March 2014 in the U.S. District Court, ... behalf of a widower whose wife had died in ... a hysterectomy that involved the use of a power ...
(Date:7/7/2015)... According to a new market research ... (Consumables, Instrument), Application (Aerobic, Anaerobic, Yeast/ Fungi) & End User ... to 2019", published by MarketsandMarkets, The global Blood Culture Tests ... $2,750.2 Million in 2014 at a CAGR of 7.2% from ... ma rket data T ables and ...
(Date:7/7/2015)... 7, 2015 C,est ... annonce l,acquisition de 20% du Groupe TRB, ... spécialisée dans la fabrication de médicaments et ...      (Logo: http://photos.prnewswire.com/prnh/20150707/232398LOGO) , ... groupes chimiques et pharmaceutiques italiens, qui contrôle, ...
Breaking Medicine Technology:Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 2Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 2Blood Culture Tests Market Worth $3,893.5 Million by 2019 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 4
... BOULDER, Colo. and MONTREAL, Jan. 9 ... Inc. (TSX: MYG) today announced,the enrollment of ... clinical trial (Trial,CL002) evaluating MGCD0103, the Companies, ... combination with,Vidaza(R) (azacitidine for injection), Pharmion,s DNA ...
... Whatever illness it is, it can make you feel ... but it is even more difficult to handle,being sick ... Diabetes Association (ADA), people with,diabetes who develop an illness ... care of their diabetes. Blood glucose levels can increase,or ...
Cached Medicine Technology:Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 2Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 3Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 4Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 5Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 6Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 7Help! I'm Sick. How Do I Handle My Diabetes? 2
Up-tapered output compresses NA to give low NA fiber performance on high NA fiber stock....
... AAA Endovascular Graft with the H&L-B One-Shot ... for the endovascular treatment of patients with ... suitable for endovascular repair. The Zenith AAA ... an aneurysm to "seal off" the aneurysm. ...
The new series of Steris Power-lift Stirrups incorporate all of the proven clinical benefits of Allen-style booted stirrups: maximum safety for the patient, ease of setup for your staff, impressive v...
... Pneumatic lift assist stirrups are designed to travel ... -30 degrees. They lock tight wherever you release ... and adduction are done at the handle with ... side rail socket. The rotation of system was ...
Medicine Products: